Avecho Biotechnology LimitedASX: AVE

First Patient dosed in Phase III insomnia trial

May 16, 2024 at 3:29 AM UTC · Issued by Avecho Biotechnology Limited

Avecho Biotechnology Ltd has released a press release.

View Attachment